Drug Shortage Report for CAVERJECT STERILE POWDER

Last updated on 2020-10-27 History
Report ID 98076
Drug Identification Number 02215756
Brand name CAVERJECT STERILE POWDER
Common or Proper name Caverject
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ALPROSTADIL
Strength(s) 23.2MCG
Dosage form(s) KIT LIQUID POWDER FOR SOLUTION
Route of administration INTRACAVERNOSAL
Packaging size 5 x 20MCG VIALS
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-29
Estimated end date 2020-10-30
Actual end date 2020-10-26
Shortage status Resolved
Updated date 2020-10-27
Company comments This shortage also includes : DIN 02215187
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2020-10-27 English Compare
v11 2020-10-26 French Compare
v10 2020-10-26 English Compare
v9 2020-10-15 French Compare
v8 2020-10-15 English Compare
v7 2020-08-03 French Compare
v6 2020-08-03 English Compare
v5 2020-02-10 French Compare
v4 2020-02-10 English Compare
v3 2020-02-10 English Compare
v2 2019-11-06 French Compare
v1 2019-11-06 English Compare